Immunoadsorption for the treatment of a patient with severe thrombotic thrombocytopenic purpura resistant to plasma exchange: kinetics of an inhibitor of ADAMTS13
- 1 January 2003
- journal article
- website
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 1 (1) , 187-189
- https://doi.org/10.1046/j.1538-7836.2003.00004.x
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Structure of von Willebrand Factor-cleaving Protease (ADAMTS13), a Metalloprotease Involved in Thrombotic Thrombocytopenic PurpuraJournal of Biological Chemistry, 2001
- Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpuraNature, 2001
- Partial amino acid sequence of purified von Willebrand factor–cleaving proteaseBlood, 2001
- Management Of Thrombotic Thrombocytopenic PurpuraBritish Journal of Haematology, 2000
- Assay of von Willebrand Factor (vWF)-cleaving Protease Based on Decreased Collagen Binding Affinity of Degraded vWFThrombosis and Haemostasis, 1999
- Antibodies to von Willebrand Factor–Cleaving Protease in Acute Thrombotic Thrombocytopenic PurpuraNew England Journal of Medicine, 1998
- von Willebrand Factor–Cleaving Protease in Thrombotic Thrombocytopenic Purpura and the Hemolytic–Uremic SyndromeNew England Journal of Medicine, 1998
- The determination of von Willebrand factor activity by collagen binding assayHaemophilia, 1998